Hvivo PLC (LON:HVO) shares fell 1.1% during mid-day trading on Monday . The stock traded as low as GBX 10.50 ($0.14) and last traded at GBX 11.50 ($0.15), 919,211 shares traded hands during trading. An increase of 1,875,841% from the average session volume of 49 shares. The stock had previously closed at GBX 11.63 ($0.15).
The company’s 50 day simple moving average is GBX 14.65 and its 200-day simple moving average is GBX 18.34. The company has a current ratio of 1.37, a quick ratio of 1.16 and a debt-to-equity ratio of 25.11. The firm has a market cap of $9.41 million and a P/E ratio of -0.58.
In related news, insider James Winschel bought 25,349 shares of the firm’s stock in a transaction on Thursday, October 3rd. The stock was acquired at an average cost of GBX 1,578 ($20.76) per share, for a total transaction of £400,007.22 ($526,186.82).
hVIVO plc, a specialty biopharma company, provides medical and scientific research services in the United Kingdom, the United States, and Europe. The company is developing a human-based analytical platform to accelerate drug discovery and development in respiratory and infectious diseases, including influenza virus, respiratory syncytial virus, asthma exacerbation, and human rhinovirus.
Read More: Preferred Stock
Receive News & Ratings for Hvivo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hvivo and related companies with MarketBeat.com's FREE daily email newsletter.